American Airlines Drops Ozempic Coverage, Flight Attendants Push Back
Ozempic may still be flying high in America, but not in American Airlines’ employee health plan. American Airlines Cuts Ozempic From Flight Attendant Healthcare Coverage Starting January 1, 2026, American Airlines flight attendants will lose insurance coverage for popular GLP-1 medications such as Ozempic and Mounjaro, unless they have a formal diagnosis of Type 2 […]
GLP-1 Drugs Help Protect Against Sleep Apnea, Study Says
By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect…
Did Eli Lilly Just Say “Checkmate” to Novo Nordisk?
Key Points Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly’s recent clinical progress sets it up for another critical approval. The company has fantastic medium-term prospects. 10 stocks we like better than Eli Lilly › Novo Nordisk (NYSE: NVO), a Denmark-based drugmaker, was a pioneer in […]
West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum
Colleges Push Back, Ozempic Price Promise, and White House vs. Anthropic
Kara and Scott discuss more schools saying no to Trump’s college “compact,” the No Kings protests, and the AWS outage. Then, Trump’s promise to slash Ozempic prices sends GLP-1 stocks tumbling. Plus, AI czar David Sacks picks a fight with Anthropic over AI regulation — and Peter Thiel warns of the Antichrist. We’re going on […]
GLP-1 Drugs, Such as Ozempic, Zepbound, Help Protect Against Sleep Apnea, Study Says
TUESDAY, Oct. 21, 2025 — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.
Type 2 diabetes patients taking GLP-1 drugs were overall less likely to die within the…
How Medical Aesthetics Practices Are Driving GLP-1 Usage Amidst Ongoing Regulatory Changes
A look at GLP-1 spend at medical aesthetics practices from 2021 to 2025, per data and analytics firm Guidepoint Qsight.
‘Awkward Moment’: Dr. Oz Interrupts Trump at Oval Office
(MedPage Today) — In what some news reports dubbed “an awkward moment,” CMS Administrator Mehmet Oz, MD, stepped up to the podium in the Oval Office last week to correct President Donald Trump on the status of GLP-1 drug costs. Trump started…
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
(MedPage Today) — The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they’ve had such an event already, Novo Nordisk announced. Semaglutide 7…
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest Physicians, held from Oct. 19 to 22 in Chicago.